MC-MIL net: A multi-cascaded dual-stream multiple instance learning diagnostic framework for castleman disease.

Abstract Introduction: Castleman disease (CD) is a rare lymphoproliferative disorder with complex pathological features, leading to challenges in clinical diagnosis. Current diagnostic methods rely on subjective assessments by pathologists, which suffer from significant observer variability and lengthy turnaround times. Although deep learning holds promise in digital pathology, its application is limited by the imbalanced data of CD. Methods: This study proposes the MC-MIL Net, a multi-cascaded architecture integrating quality-aware preprocessing and context-enhanced representation learning to address data imbalance through data decomposition and reorganization. The framework employs a four-stage cascaded analysis pipeline: First, morphological operations and HSV color space decomposition assess tissue integrity and staining quality. Second, a sample clustering and reorganization strategy adjusts label ratios. Third, ResNet-34/50 is used for feature extraction. Finally, a dual-path decision-making mechanism combines a macro-stream (similarity-weighted fusion) and a micro-stream (attention-based screening). Three-stage transfer learning is adopted to enhance generalization. Results: Validation across two medical centers demonstrated an average accuracy of 94.55% in five-fold cross-validation at the primary center, with the best AUC reaching 1.00. In cross-center validation, direct transfer learning achieved an accuracy of 81.08%, while fine-tuning with 15% of the data yielded an AUC of 1.00. Full fine-tuning with 85% of the data further improved accuracy to 90.91%.Conclusions: This study enhances diagnostic performance through quality-aware preprocessing and data-balancing strategies, demonstrating that fine-tuning with minimal data can achieve excellent results. It provides a novel approach to rare disease diagnosis. Future work will extend this framework to CD subtype classification and treatment prediction.

Authors

Institutions

Publication Details

Journal
Blood
Published
2025-11-03
DOI
https://doi.org/10.1182/blood-2025-7858
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MC-MIL net: A multi-cascaded dual-stream multiple instance learning diagnostic framework for castleman disease.

Yuan Miao, Xue Shi, Ying Ma, Yue Liu et al.
Blood
AI in cancer detection
article

MC-MIL net: A multi-cascaded dual-stream multiple instance learning diagnostic framework for castleman disease.

Yuan Miao, Xue Shi, Ying Ma, Yue Liu, Yin Dai, Rui Zhang, Hui-Han Wang, Jian Li
article en

Abstract

Abstract Introduction: Castleman disease (CD) is a rare lymphoproliferative disorder with complex pathological features, leading to challenges in clinical diagnosis. Current diagnostic methods rely on subjective assessments by pathologists, which suffer from significant observer variability and lengthy turnaround times. Although deep learning holds promise in digital pathology, its application is limited by the imbalanced data of CD. Methods: This study proposes the MC-MIL Net, a multi-cascaded architecture integrating quality-aware preprocessing and context-enhanced representation learning to address data imbalance through data decomposition and reorganization. The framework employs a four-stage cascaded analysis pipeline: First, morphological operations and HSV color space decomposition assess tissue integrity and staining quality. Second, a sample clustering and reorganization strategy adjusts label ratios. Third, ResNet-34/50 is used for feature extraction. Finally, a dual-path decision-making mechanism combines a macro-stream (similarity-weighted fusion) and a micro-stream (attention-based screening). Three-stage transfer learning is adopted to enhance generalization. Results: Validation across two medical centers demonstrated an average accuracy of 94.55% in five-fold cross-validation at the primary center, with the best AUC reaching 1.00. In cross-center validation, direct transfer learning achieved an accuracy of 81.08%, while fine-tuning with 15% of the data yielded an AUC of 1.00. Full fine-tuning with 85% of the data further improved accuracy to 90.91%.Conclusions: This study enhances diagnostic performance through quality-aware preprocessing and data-balancing strategies, demonstrating that fine-tuning with minimal data can achieve excellent results. It provides a novel approach to rare disease diagnosis. Future work will extend this framework to CD subtype classification and treatment prediction.

BloodVol. 146(Supplement 1)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), First Hospital of China Medical University (CN), China Medical University (CN), Northeastern University (CN)
Openalex Percentile: Top 79%
AI in cancer detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.